IDN Summit and Reverse Expo: Pharmacy Track: Pricing Legislation, Administrative Actions & New Entrants to the Drug Manufacturing Market

Steven J. Schnelle joins the IDN Summit to discuss pricing legislation, administrative actions and new entrants to the drug and manufacturing market. Steven’s panel will uncover the potential far-reaching implications of complex changes to drug pricing as legislatures and regulators strive to lower prices and out-of-pocket costs for patients through greater transparency in drug prices and rebates.

Learn more and register here.